Global Tissue Imaging Market Analysis, 2021

Market Overview

According to the publisher’ research report, “Global Tissue Imaging Market Analysis, 2021”, the market is likely to grow at a CAGR of around 8.96% during 2021-26 due to factors like the increasing identification of the early detection of diseases & diagnosis and growth of chronic disease cases. Alongside that, extensive investments by businesses across the globe in the healthcare sector and advanced technologies like AI & machine learning algorithms due to their efficiency in the early detection of diseases and their treatment are other prominent factors contributing to the market growth.

Impact of COVID-19

The outbreak of the Covid-19 pandemic had the most significant impact on the market and brought extensive challenges, especially in the pharmaceutical industry globally. It is now challenging for industries to return to their optimum pace, especially in developing countries across different regions. Further, the impact of the pandemic reduced the overall trade and imports, leading to a significant downfall in the market. However, with the gradual lifting of restrictions by governments, the market growth is likely to regain its pace in the forecast period.

Market Segmentation

Digital Pathology To Fuel The Market Share

Based on technology type, Digital Pathology is likely to fuel market growth in the coming years. The key factors leading to the rise include high-tech contributors with their predominant preference for synergistic activities like collaborations to sustain the enforcement globally and improve dominance. Hence, the global tissue imaging market is likely to witness substantial growth in the forecast years, reveals the author in their research report, Global Tissue Imaging Market Analysis, 2021.

Hospitals & Diagnostic Laboratories To Possess Largest Market Share

Based on End-User Industries, Hospitals & Diagnostic Laboratories are likely to possess the largest market share in the forecast period due to the increasing cases of people with chronic diseases that need tools for tissue imaging and the integration of digital technology in tissue imaging. Moreover, a gradual shift towards better infrastructure of hospitals, operation rooms, and healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.

Regional Landscape

Asia-Pacific Attains The Fastest Growth

Asia-Pacific region is likely to attain the fastest growth in the global tissue imaging market. Several factors contributing to the rapid rise of demand and supply requirements in the APAC region are the rising incidents of chronic diseases & contagious conditions in patients, the growing biotechnology & pharmaceutical industries, and surging activities, including R&D in imaging procedures in the APAC.

Market Driver

Although the COVID-19 pandemic led to a significant downfall of the market, however, Global Tissue Imaging Market is likely to regain its speed in the forecast period. The factors that shall boost the market growth are the growing cases of people with chronic diseases & disorders that require tissue imaging and Digital Technology. Furthermore, a shift towards value-oriented healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.

Competitive Landscape

According to the publishers, the major leading players in the Global Tissue Imaging Market are Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others.

Key questions answered in the study

1. What are the current and future trends in the Global Tissue Imaging Market?
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Global Tissue Imaging Market?
5. What are the customer orientation, purchase behavior, and expectations from the Global Tissue Imaging Market service providers across various regions?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Definition

2. Executive Summary3. Impact of COVID-19 on Global Tissue Imaging Market4. Global Tissue Imaging Market Trends & Insights

5. Global Tissue Imaging Market Dynamics

5.1. Drivers
5.2. Challenges
5.3. Impact Analysis

6. Global Tissue Imaging Market Hotspots & Opportunities7. Global Tissue Imaging Market Supply & Demand Analysis

8. Global Tissue Imaging Market Regulations & Policy

8.1. By Region
8.1.1. North America
8.1.1.1. The US
8.1.2. Europe
8.1.3. Asia Pacific
8.1.3.1. Japan
8.1.3.2. China
8.1.3.3. India
8.1.4. Middle East & Africa

9. Global Tissue Imaging Market Patent Analysis10. List of Associations/Consortiums/Regulatory Bodies (with Establishment Year, and Region)

11. Global Tissue Imaging Market Outlook, 2016-2026F

11.1. Market Size & Analysis
11.1.1. By Revenues
11.2. Market Share & Analysis
11.2.1. By Technology
11.2.1.1. Mass Spectroscopy
11.2.1.1.1. MALDI Imaging
11.2.1.1.2. DESI Imaging
11.2.1.1.3. SIMS Imaging
11.2.1.2. Immunohistochemistry (IHC)
11.2.1.3. Flow Cytometry
11.2.1.4. Digital Pathology
11.2.1.5. In Situ Hybridization (ISH)
11.2.1.5.1. Fluorescence In-Situ Hybridization (FISH)
11.2.1.5.1.1. DNA Fluorescence In-Situ Hybridization
11.2.1.5.1.2. RNA Fluorescence In-Situ Hybridization
11.2.1.5.1.3. Protein Fluorescence In-Situ Hybridization
11.2.1.5.2. Chromogenic In-Situ Hybridization (CISH)
11.2.1.6. Immunofluorescence
11.2.1.6.1. Indirect Immunofluorescence (Secondary)
11.2.1.6.2. Direct Immunofluorescence (Primary)
11.2.2. By Product
11.2.2.1. Platforms
11.2.2.1.1. Mass Spectroscopy Imaging (MSI) platforms
11.2.2.1.2. Flow Cytometry Analyzers
11.2.2.1.3. Digital Pathology Scanners
11.2.2.1.4. Immunohistochemistry Detection Systems
11.2.2.1.5. In-Situ Hybridization Platforms
11.2.2.1.6. Immunofluorescence Imaging Analysis Systems
11.2.2.1.7. Tissue Microarray Platforms
11.2.2.2. Microscopes
11.2.2.2.1. Optical Microscopes
11.2.2.2.1.1. Compound Microscopes
11.2.2.2.1.2. Digital Microscopes
11.2.2.2.1.3. Fluorescence Microscopes
11.2.2.2.1.4. Others
11.2.2.2.2. Electron Microscopes
11.2.2.2.2.1. Scanning Electron Microscopes (SEM)
11.2.2.2.2.2. Transmission Electron Microscopes (TEM)
11.2.2.2.3. Scanning Probe Microscopes
11.2.2.2.4. Others
11.2.2.3. Consumables
11.2.2.3.1. Antibodies & Reagents
11.2.2.3.2. Kits
11.2.2.3.3. Probes
11.2.2.3.4. Others
11.2.2.4. Software
11.2.2.5. Accessories
11.2.3. By Therapeutic Application
11.2.3.1. By Disease Research
11.2.3.1.1. Oncology Research
11.2.3.1.2. Infectious Diseases Research
11.2.3.1.3. Neurological Disease Research
11.2.3.1.4. Cardiovascular Disease Research
11.2.3.1.5. Immunological Disease Research
11.2.3.1.6. Other Diseases Research
11.2.3.2. By Diagnostics
11.2.3.2.1. Oncology Diagnostics
11.2.3.2.2. Infectious Diseases Diagnostics
11.2.3.2.3. Neurological Disease Diagnostics
11.2.3.2.4. Cardiovascular Disease Diagnostics
11.2.3.2.5. Immunological Disease Diagnostics
11.2.3.2.6. Others Diseases Diagnostics
11.2.4. By End User
11.2.4.1. Biotechnology Companies
11.2.4.2. Pharmaceutical Companies
11.2.4.3. Contract Research Organizations (CROs)
11.2.4.4. Academic and Research Institutions
11.2.4.5. Hospitals and Diagnostic Laboratories
11.2.5. By Region
11.2.5.1. North America
11.2.5.2. Latin America
11.2.5.3. Europe
11.2.5.4. Middle East & Africa
11.2.5.5. Asia-Pacific
11.2.6. By Competitors
11.2.6.1. Competition Characteristics
11.2.6.2. Market Share & Analysis
11.2.6.3. Competitive Matrix

12. North America Tissue Imaging Market Outlook, 2016-2026F

12.1. Market Size & Analysis
12.1.1. By Revenues
12.2. Market Share & Analysis
12.2.1. By Technology
12.2.2. By Product
12.2.3. By Therapeutic Application
12.2.4. By End User
12.2.5. By Country
12.2.5.1. The U.S.
12.2.5.2. Canada
12.3. The U.S. Tissue Imaging Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. By Revenues
12.3.2. Market Share & Analysis
12.3.2.1. By Technology
12.3.2.2. By Product
12.3.2.3. By Therapeutic Application
12.3.2.4. By End User
12.4. Canada Tissue Imaging Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. By Revenues
12.4.2. Market Share & Analysis
12.4.2.1. By Technology
12.4.2.2. By Product
12.4.2.3. By Therapeutic Application
12.4.2.4. By End User

13. Latin America Tissue Imaging Market Outlook, 2016-2026F

13.1. Market Size & Analysis
13.1.1. By Revenues
13.2. Market Share & Analysis
13.2.1. By Technology
13.2.2. By Product
13.2.3. By Therapeutic Application
13.2.4. By End User
13.2.5. By Country
13.2.5.1. Brazil
13.2.5.2. Mexico
13.3. Brazil Tissue Imaging Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. By Revenues
13.3.2. Market Share & Analysis
13.3.2.1. By Technology
13.3.2.2. By Product
13.3.2.3. By Therapeutic Application
13.3.2.4. By End User
13.4. Mexico Tissue Imaging Market Outlook, 2016-2026F
13.4.1. Market Size & Analysis
13.4.1.1. By Revenues
13.4.2. Market Share & Analysis
13.4.2.1. By Technology
13.4.2.2. By Product
13.4.2.3. By Therapeutic Application
13.4.2.4. By End User

14. Europe Tissue Imaging Market Outlook, 2016-2026F

14.1. Market Size & Analysis
14.1.1. By Revenues
14.2. Market Share & Analysis
14.2.1. By Technology
14.2.2. By Product
14.2.3. By Therapeutic Application
14.2.4. By End User
14.2.5. By Country
14.2.5.1. The U.K.
14.2.5.2. Germany
14.2.5.3. France
14.2.5.4. Rest of Europe
14.3. The U.K. Tissue Imaging Market Outlook, 2016-2026F
14.3.1. Market Size & Analysis
14.3.1.1. By Revenues
14.3.2. Market Share & Analysis
14.3.2.1. By Technology
14.3.2.2. By Product
14.3.2.3. By Therapeutic Application
14.3.2.4. By End User
14.4. Germany Tissue Imaging Market Outlook, 2016-2026F
14.4.1. Market Size & Analysis
14.4.1.1. By Revenues
14.4.2. Market Share & Analysis
14.4.2.1. By Technology
14.4.2.2. By Product
14.4.2.3. By Therapeutic Application
14.4.2.4. By End User
14.5. France Tissue Imaging Market Outlook, 2016-2026F
14.5.1. Market Size & Analysis
14.5.1.1. By Revenues
14.5.2. Market Share & Analysis
14.5.2.1. By Technology
14.5.2.2. By Product
14.5.2.3. By Therapeutic Application
14.5.2.4. By End User
14.6. Rest of Europe Tissue Imaging Market Outlook, 2016-2026F
14.6.1. Market Size & Analysis
14.6.1.1. By Revenues
14.6.2. Market Share & Analysis
14.6.2.1. By Technology
14.6.2.2. By Product
14.6.2.3. By Therapeutic Application
14.6.2.4. By End User

15. Middle East & Africa (MEA) Tissue Imaging Market Outlook, 2016-2026F

15.1. Market Size & Analysis
15.1.1. By Revenues
15.2. Market Share & Analysis
15.2.1. By Technology
15.2.2. By Product
15.2.3. By Therapeutic Application
15.2.4. By End User
15.2.5. By Country
15.2.5.1. UAE
15.2.5.2. Saudi Arabia
15.2.5.3. South Africa
15.2.5.4. Rest of MEA
15.3. UAE Tissue Imaging Market Outlook, 2016-2026F
15.3.1. Market Size & Analysis
15.3.1.1. By Revenues
15.3.2. Market Share & Analysis
15.3.2.1. By Technology
15.3.2.2. By Product
15.3.2.3. By Therapeutic Application
15.3.2.4. By End User
15.4. Saudi Arabia Tissue Imaging Market Outlook, 2016-2026F
15.4.1. Market Size & Analysis
15.4.1.1. By Revenues
15.4.2. Market Share & Analysis
15.4.2.1. By Technology
15.4.2.2. By Product
15.4.2.3. By Therapeutic Application
15.4.2.4. By End User
15.5. South Africa Tissue Imaging Market Outlook, 2016-2026F
15.5.1. Market Size & Analysis
15.5.1.1. By Revenues
15.5.2. Market Share & Analysis
15.5.2.1. By Technology
15.5.2.2. By Product
15.5.2.3. By Therapeutic Application
15.5.2.4. By End User
15.6. Rest of Middle East & Africa (MEA) Tissue Imaging Market Outlook, 2016-2026F
15.6.1. Market Size & Analysis
15.6.1.1. By Revenues
15.6.2. Market Share & Analysis
15.6.2.1. By Technology
15.6.2.2. By Product
15.6.2.3. By Therapeutic Application
15.6.2.4. By End User

16. Asia-Pacific Tissue Imaging Market Outlook, 2016-2026F

16.1. Market Size & Analysis
16.1.1. By Revenues
16.2. Market Share & Analysis
16.2.1. By Technology
16.2.2. By Product
16.2.3. By Therapeutic Application
16.2.4. By End User
16.2.5. By Country
16.2.5.1. China
16.2.5.2. India
16.2.5.3. Japan
16.2.5.4. South Korea
16.2.5.5. Australia
16.2.5.6. Rest of Asia-Pacific
16.3. India Tissue Imaging Market Outlook, 2016-2026F
16.3.1. Market Size & Analysis
16.3.1.1. By Revenues
16.3.2. Market Share & Analysis
16.3.2.1. By Technology
16.3.2.2. By Product
16.3.2.3. By Therapeutic Application
16.3.2.4. By End User
16.4. China Tissue Imaging Market Outlook, 2016-2026F
16.4.1. Market Size & Analysis
16.4.1.1. By Revenues
16.4.2. Market Share & Analysis
16.4.2.1. By Technology
16.4.2.2. By Product
16.4.2.3. By Therapeutic Application
16.4.2.4. By End User
16.5. Japan Tissue Imaging Market Outlook, 2016-2026F
16.5.1. Market Size & Analysis
16.5.1.1. By Revenues
16.5.2. Market Share & Analysis
16.5.2.1. By Technology
16.5.2.2. By Product
16.5.2.3. By Therapeutic Application
16.5.2.4. By End User
16.6. South Korea Tissue Imaging Market Outlook, 2016-2026F
16.6.1. Market Size & Analysis
16.6.1.1. By Revenues
16.6.2. Market Share & Analysis
16.6.2.1. By Technology
16.6.2.2. By Product
16.6.2.3. By Therapeutic Application
16.6.2.4. By End User
16.7. Australia Tissue Imaging Market Outlook, 2016-2026F
16.7.1. Market Size & Analysis
16.7.1.1. By Revenues
16.7.2. Market Share & Analysis
16.7.2.1. By Technology
16.7.2.2. By Product
16.7.2.3. By Therapeutic Application
16.7.2.4. By End User
16.8. Rest of Asia-Pacific Tissue Imaging Market Outlook, 2016-2026F
16.8.1. Market Size & Analysis
16.8.1.1. By Revenues
16.8.2. Market Share & Analysis
16.8.2.1. By Technology
16.8.2.2. By Product
16.8.2.3. By Therapeutic Application
16.8.2.4. By End User

17. Key Strategic Imperatives for Success and Growth

18. Competition Outlook

18.1. Competition Matrix
18.1.1. Brand Specialization
18.1.2. Target Markets
18.1.3. Target End Users
18.1.4. Research & Development
18.1.5. Strategic Alliances
18.1.6. Strategic Initiatives
18.2. Company Profiles
18.2.1. Abbott Laboratories
18.2.2. Roche Holding AG
18.2.3. Bio-Rad Laboratories, Inc.
18.2.4. Bio SB
18.2.5. Agilent Technologies
18.2.6. Olympus Corporation
18.2.7. Abcam Plc
18.2.8. Biocare Medical LLC
18.2.9. Sakura Finetek
18.2.10. LifeSpan BioSciences, Inc.
18.2.11. Hamamatsu Photonics K.K.
18.2.12. Fluidigm Corporation
18.2.13. Danaher Corporation
18.2.14. Merck KGaA
18.2.15. Thermo Fisher Scientific Inc.
18.2.16. Becton, Dickinson and Company
18.2.17. F. Hoffmann-La Roche Ltd
18.2.18. Vector Laboratories
18.2.19. Shimadzu Corporation
18.2.20. Nikon Corporation
18.2.21. PerkinElmer Inc.

19. Disclaimer